347 related articles for article (PubMed ID: 18645702)
1. Lipids, statins and cardiovascular disease.
Cheifitz R
Climacteric; 2008 Aug; 11(4):347-8; author reply 348-50. PubMed ID: 18645702
[No Abstract] [Full Text] [Related]
2. The role of statins in managing diabetic dyslipidemia.
Toth PP
J Fam Pract; 2010 May; 59(5 Suppl):S23-9. PubMed ID: 20544054
[TBL] [Abstract][Full Text] [Related]
3. Questioning the benefits of statins.
Mazowita G
CMAJ; 2005 Nov; 173(10):1210; author reply 1210. PubMed ID: 16275979
[No Abstract] [Full Text] [Related]
4. Lipid screening and cardiovascular health in childhood.
Daniels SR; Greer FR;
Pediatrics; 2008 Jul; 122(1):198-208. PubMed ID: 18596007
[TBL] [Abstract][Full Text] [Related]
5. [Prevalence and characteristics of lipid abnormalities in patients treated with statins in primary and secondary prevention in Spain. DYSIS-Spain Study].
González-Juanatey JR; Millán J; Alegría E; Guijarro C; Lozano JV; Vitale GC
Rev Esp Cardiol; 2011 Apr; 64(4):286-94. PubMed ID: 21411216
[TBL] [Abstract][Full Text] [Related]
6. Statins.
Ratchford EV; Martin SS
Vasc Med; 2017 Oct; 22(5):442-445. PubMed ID: 28803537
[No Abstract] [Full Text] [Related]
7. [Chronic kidney disease and statins].
Matovinović MS
Lijec Vjesn; 2006; 128(11-12):345-50. PubMed ID: 17212196
[TBL] [Abstract][Full Text] [Related]
8. The editor's roundtable: lipid management beyond statins-reducing residual cardiovascular risk.
Friedewald VE; Ballantyne CM; Davidson MH; Guyton JR; Roberts WC
Am J Cardiol; 2008 Sep; 102(5):559-67. PubMed ID: 18721512
[No Abstract] [Full Text] [Related]
9. Primary prevention: dyslipidaemia.
Pignone M
Clin Evid; 2005 Dec; (14):142-50. PubMed ID: 16620402
[No Abstract] [Full Text] [Related]
10. [Statins in chronic renal disease].
Ferreira SR; Rocha AM; Saraiva JF
Arq Bras Cardiol; 2005 Oct; 85 Suppl 5():45-9. PubMed ID: 16400399
[TBL] [Abstract][Full Text] [Related]
11. Statins: Are they really all the same?
Cortese F
Curr Vasc Pharmacol; 2019; 17(3):211-212. PubMed ID: 30003860
[No Abstract] [Full Text] [Related]
12. On the road to better dyslipidemia outcomes.
Hughes S
Nurse Pract; 2009 Feb; 34(2):14-21; quiz 22. PubMed ID: 19155874
[No Abstract] [Full Text] [Related]
13. Questioning the benefits of statins.
Vos E; Rose CP
CMAJ; 2005 Nov; 173(10):1207; author reply 1210. PubMed ID: 16275976
[No Abstract] [Full Text] [Related]
14. Statins' role in prevention. Do statins have a role in primary prevention of cardiovascular events?
Can Fam Physician; 2004 Aug; 50():1091. PubMed ID: 15455806
[No Abstract] [Full Text] [Related]
15. Lipid abnormalities and cardiovascular risk in renal disease.
Ritz E; Wanner C
J Am Soc Nephrol; 2008 Jun; 19(6):1065-70. PubMed ID: 18369085
[TBL] [Abstract][Full Text] [Related]
16. Treatment of the dyslipidemia of insulin resistance.
Smith DA
Med Clin North Am; 2007 Nov; 91(6):1185-210, x. PubMed ID: 17964916
[TBL] [Abstract][Full Text] [Related]
17. Pharmacotherapy of dyslipidemias in the adult population.
Vigna GB; Fellin R
Expert Opin Pharmacother; 2010 Dec; 11(18):3041-52. PubMed ID: 20958118
[TBL] [Abstract][Full Text] [Related]
18. Modulation of eicosanoid production and activity as a potential explanation for some of the pleiotropic effects of statins.
Birnbaum Y; Ye Y; Farmer J
Cardiology; 2010; 116(1):45-7. PubMed ID: 20431292
[No Abstract] [Full Text] [Related]
19. Cross-talk between statins and PPARalpha in cardiovascular diseases: clinical evidence and basic mechanisms.
Paumelle R; Staels B
Trends Cardiovasc Med; 2008 Apr; 18(3):73-8. PubMed ID: 18436144
[TBL] [Abstract][Full Text] [Related]
20. [The JUPITER study: an orbit still very far from the Mediterranean countries].
Puddu PE
G Ital Cardiol (Rome); 2010 Sep; 11(9):708-9. PubMed ID: 21351377
[No Abstract] [Full Text] [Related]
[Next] [New Search]
